`
`PAUL
`
`HASTINGS
`
`Home > Professionals > Evan D. Diamond
`
`EVAN D. DIAMOND
`
`Associate, Litigation Department
`
`New York
`T 1(212) 318-6004
`F 1(212) 230-5104
`
`evandiamond@paulhastings.com
`Download VCard I Download PDF
`
`Evan D. Diamond is an associate in the Life Sciences Intellectual
`Property practice of Paul Hastings. Mr. Diamond's practice focuses
`on patent litigation matters in the fields of pharmaceuticals and
`biotechnology. Mr. Diamond has represented clients in federal
`district court litigations, in appeal proceedings before the Federal
`Circuit, and in inter partes review proceedings before the Patent
`Trials and Appeals Board. In addition, Mr. Diamond has provided
`strategic counseling to clients regarding potential litigation and
`other patent-related matters.
`
`Experience
`
`Galderma Laboratories, L.P. and Supernus
`Pharmaceuticals, Inc.: Patent infringement litigation relating
`to the rosacea treatment Oracea®. Successfully upheld
`validity of longest-running patent covering Oracea® in federal
`district court, followed by a per curiam affirmance by the
`Federal Circuit. Successfully obtained preliminary injunction
`precluding generic launch prior to patent expiration. Continued
`to defend against subsequent challenges to patents covering
`Oracea® in federal district court and in inter partes review
`proceedings.
`
`Eisai Inc.: Patent infringement litigation regarding
`Targretin®, a treatment for cutaneous T-cell lymphoma.
`
`Forest Laboratories, Inc. and Merz Pharmaceuticals
`GmbH: Patent infringement litigation relating to Alzheimer's
`disease treatment Namenda®.
`
`PRACTICE AREAS
`
`Litigation
`
`Life Sciences
`
`Patent Office
`
`Patent Litigation
`
`Intellectual Property
`
`ADMISSIONS
`
`New York Bar
`
`EDUCATION
`
`Harvard Law School,
`ID., 2007
`University of
`Pennsylvania, B.A.,
`2004
`University of
`Pennsylvania, M.S.,
`2004
`
`NEWS
`
`Paul Hastings Achieves
`First Ever Win in New
`Form of IP Proceeding
`for Pharmaceutical
`Company
`
`December 11, 2014
`
`INSIGHTS
`
`Paul Hastings Wins for
`Galderma and Supernus
`in First Hatch-Waxman
`Inter Partes Reviews to
`Reach Final Written
`Decision
`
`December 10, 2014
`
`Friday, September 11, 2015 (cid:9)
`
`Page 1 of 2
`
`Galderma Laboratories, Inc., Ex. 2002
`Dr. Reddy’s Labs. V. Galderma Labs., Inc.
`IPR2015-01777
`
`000001
`
`
`
`
`
`http://www.paulhastings.com/professionals/details/evandiamond
`
`Forest Laboratories, Inc. and H. Lundbeck A/S: Patent
`infringement litigation concerning the multi-billion dollar drug
`product Lexapro®, a selective serotonin reuptake inhibitor
`indicated for the treatment of depression and anxiety.
`
`Accolades and Recognitions
`
`Financial Times, U.S. Innovative Lawyers 2012: top "Standout"
`rating in Intellectual Property awarded to Paul Hastings for
`representation of Galderma in Oracea® litigation
`
`FDA Issues Draft
`Guidance on Reference
`Product Exclusivity for
`Biologics
`
`August 07, 2014
`
`Paul Hastings Wins
`Federal Circuit
`Affirmance Upholding
`Key Patent Covering
`Once-Daily Formulation
`for ORACEA
`
`Law360, Life Sciences Group of the Year (2013), awarded to
`Paul Hastings for representations including Galderma in
`Oracea® litigation
`
`Honorable Mention, H. Thomas Austern Memorial Writing
`Competition, Food and Drug Law Institute (2008)
`
`August 09, 2013
`
`Read More [+/-]
`
`RANKINGS &
`AWARDS
`
`Speaking Engagements and Publications
`
`Panelist, "Predictions Related to Biosimilars
`Challenges" (NewYorkBIO Conference, May 2014)
`
`E. Diamond, "Reverse-FOIA Limitations on Agency Actions to
`Disclose Human Gene Therapy Clinical Data," 63 Food & Drug
`L. J. 321 (2008)
`
`G.S. Pesiridis, E. Diamond, and G.D. Van Duyne, "Role of pICIn
`in Methylation of Sm Proteins by PRMT5," J. Biol. Chem. (2009)
`284:21347-21359
`
`Education
`
`Harvard Law School, J.D. (cum laude), 2007
`
`University of Pennsylvania, B.A. in Biochemistry (summa cum
`laude, Phi Beta Kappa), 2004
`
`University of Pennsylvania, M.S. in Chemistry, 2004
`
`Legal Media Group's
`2013 LMG Life
`Science Awards
`The firm was nominated
`as a 2013 LMG Life
`Science nominee in the
`"Litigation Team of the
`Year" and "(General)
`Patent Litigation: Firm
`of the Year" categories.
`
`August 12, 2013
`
`Intellectual
`Property
`
`Intellectual Property
`Magazine
`Intellectual Property
`Magazine recognized
`Paul Hastings' IP
`Pharmaceutical Team as
`the Pharmaceutical
`Team of the Year.
`
`November 30, 2010
`
`Friday, September 11, 2015 (cid:9)
`
`Page 2 of 2
`
`Galderma Laboratories, Inc., Ex. 2002
`Dr. Reddy’s Labs. V. Galderma Labs., Inc.
`IPR2015-01777
`
`000002
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
